Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbo ciclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the 1 * 50 mg
MDEXHY-50767
Frequently Bought Together